Extending plant powders

Related tags Manufacturing

In the US this week, supplier of botanical extracts for the
pharmaceutical industry Pharmachem Laboratories announced that it
has acquired 'the largest botanical extraction facility in North
America, producing extracts for the fragrance, pharmaceutical and
dietary supplement industries.'

In the US this week, supplier of botanical extracts for the pharmaceutical industry Pharmachem Laboratories announced that it has acquired 'the largest botanical extraction facility in North America, producing extracts for the fragrance, pharmaceutical and dietary supplement industries.'

Acquired from the Avoca Division of R. J. Reynolds Tobacco company, the 172,000 sq. ft. facility has a current extraction capacity of 90,000 tons per year, including a continuous-flow Crown extractor with a daily capacity of 5-10 tons.

For the president of Pharmachem Laboratories​ David A. Holmes, this latest acquisition will not only provide the company 'with the added manufacturing capacities we need for our expanding extraction and drying business'.

But will furnish it with an R&D capability "unmatched in the natural products industry."

Under terms of the agreement Avoca will continue to function as a subsidiary of Pharmachem although the buyer is already planning a major expansion there for increased capacities and technologies. The company added in a statement that the facility meets industry standards for current good manufacturing practices (cGMP) and features on-site storage of raw materials and a cGMP finished goods warehouse.

Related products

show more

Increasing the Bioavailability of Oncology Drugs

Increasing the Bioavailability of Oncology Drugs

Content provided by Lonza Small Molecules | 13-Nov-2023 | White Paper

Oral tyrosine kinase inhibitors (TKIs) are a class of cancer drugs that can be highly susceptible to issues with solubility in the gastrointestinal tract

Efficient Freezing & Storage of Biopharmaceuticals

Efficient Freezing & Storage of Biopharmaceuticals

Content provided by Single Use Support | 06-Nov-2023 | White Paper

Various options exist for freezing biopharmaceutical bulk material, but selecting the most effective and efficient approach for each cold chain can be...

Manufacturing Drugs with Highly Potent APIs

Manufacturing Drugs with Highly Potent APIs

Content provided by Altasciences | 28-Sep-2023 | White Paper

In this issue of The Altascientist, we examine the critical considerations for the safe and compliant manufacture of drugs with highly potent APIs (HPAPIs),...